Insmed | Kostnadene For Salg

Cost Of Sales Endring Dato
BioMarin Pharmaceutical USD 135.48M 10.73M 2023-12
Dynavax Technologies USD 8.69M 4.54M 2023-12
Gilead Sciences USD 1.61B 46M 2023-12
Heron Therapeutics USD 18.21M 1.95M 2023-09
Insmed USD 18.44M 1.74M 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Sarepta Therapeutics USD 37.03M 2.9M 2023-09
Ultragenyx Pharmaceutical USD 12.05M 1.06M 2023-12
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



Insmed Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.